Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5000 participants
OBSERVATIONAL
2012-10-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling.
The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone.
Prospective data collection is performed using established clinical databases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
NCT05410977
Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
NCT01582841
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer
NCT03047226
Evaluating the Cologuard Test for Use in Lynch Syndrome
NCT04778566
Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer
NCT00516230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All colorectal cancer patients
Observation
Observation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Observation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed at one of the departments of pathology in Denmark
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vejle Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pathology
Aalborg, , Denmark
Department of Clinical Genetics
Aarhus, , Denmark
Department of Pathology
Aarhus, , Denmark
Department of Pathology
Esbjerg, , Denmark
Department of Pathology
Hjørring, , Denmark
Department of Clinical Genetics
Odense, , Denmark
Department of Pathology
Odense, , Denmark
Department of Pathology
Sønderborg, , Denmark
Vejle Hospital
Vejle, , Denmark
Department of Clinical Genetics
Vejle, , Denmark
Department of Pathology
Vejle, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS-LS-DK-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.